Mony Ung
Impact in
-
- Metastasis and carcinoma case studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 7
- HER2/EGFR in Cancer Research 4
- Co-authors
- Julien Mazières (3 shared papers)Thibault Vieira (2 shared papers)Jacques L. Cadranel (2 shared papers)Nicolas Girard (2 shared papers)Marie Wislez (2 shared papers)Martine Antoine (2 shared papers)Pierre Bonnette (1 shared paper)Aurélie Cazes (1 shared paper)
- Journals
- The Breast (4 papers)Breast Cancer Research and Treatment (2 papers)Annals of Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- France
In The Last Decade
Mony Ung
20 papers receiving 496 citations
Mony Ung's Hit Papers
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 339
- Oncology 208
- Cancer Research 91
- Radiology, Nuclear Medicine and Imaging 37
- Otorhinolaryngology 3
Countries citing papers authored by Mony Ung
This map shows the geographic impact of Mony Ung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mony Ung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mony Ung more than expected).
Fields of papers citing papers by Mony Ung
This network shows the impact of papers produced by Mony Ung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mony Ung. The network helps show where Mony Ung may publish in the future.
Co-authors
The 25 scholars most cited alongside Mony Ung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 172 | |
| 2 | Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01 Hit paper breakdown → | 2024 | 113 |
| 3 | 2015 | 80 | |
| 4 | 2016 | 80 | |
| 5 | 2023 | 12 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 1 |
About Mony Ung
Mony Ung is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Pharmacology, having authored 21 papers that have together received 502 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Treatments and Mutations (2 papers), Breast Implant and Reconstruction (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Metastasis and carcinoma case studies (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (339 citations), Oncology (208 citations), Cancer Research (91 citations), Radiology, Nuclear Medicine and Imaging (37 citations) and Otorhinolaryngology (3 citations). Mony Ung has collaborated with scholars based in France. Frequent co-authors include Julien Mazières, Thibault Vieira, Jacques L. Cadranel, Nicolas Girard, Marie Wislez, Martine Antoine, Pierre Bonnette, Aurélie Cazes, I. Monnet and M. Duruisseaux. Their work appears in journals such as The Breast, Breast Cancer Research and Treatment, Annals of Oncology, Cancer Chemotherapy and Pharmacology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.